Contract Manufacturing Industry News
-
Viropro, Inc. To Unlock Value From Its Biosimilars Portfolio
5/21/2012
Viropro, Inc. creates a technology subsidiary to focus on the burgeoning International market for biosimilar drug therapeutics. Over the past year, several of the large pharmas have tied up with Contract Research Organizations (CROs) and/or with Contract Manufacturing Organizations (CMOs) to enter the field of biosimilars.
-
Evotec Becomes The First Contract Research Facility In Europe To Offer Agilent's RapidFire/MS Screening For Pharmaceutical Drug Discovery
5/16/2012
Evotec AG is proud to announce the addition of Agilent Technologies' RapidFire Mass Spectrometry analysis capabilities to their High Throughput Screening facilities in Hamburg.
-
Avalanche Biotechnologies, Inc. And Lonza Announce Global Manufacturing Collaboration For Adeno-Associated Viral Vectors For Gene Therapy
5/16/2012
Avalanche Biotechnologies, Inc., a leader in the area of long-term protein delivery for ocular diseases, and Lonza, a global leader in the field of biologics manufacturing, recently announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy.
-
Contract Manufacturing In India And China Backed By Government Policies
5/16/2012
Contract Manufacturing Organizations (CMO) will reap the rewards as pharmaceutical production becomes increasingly globalized, according to a new report by business intelligence experts GBI Research.
-
Contract Research Organizations Set To Experience Rapid Growth As Development Costs For New Drugs Continue To Rise
5/15/2012
Global Information Inc. is pleased to announce two significant new reports on Drug Development:
-
Vetter Prepares For Further Growth
4/26/2012
As part of its business growth strategy, Vetter, a leading contract development and manufacturing organization (CDMO), has announced that a triple-digit million euro syndicated loan has been arranged with a consortium of renowned banks led by Deutsche Bank AG, the Landesbank Baden-Württemberg, and Commerzbank AG at the end of march.
-
Dalton Announces Collaboration Developing A Promising Broad Spectrum Antiviral Agent
4/25/2012
Dalton Pharma Services today announced a manufacturing agreement for a potent antiviral agent developed by Defense Research and Development Canada (DRDC), an agency of the Department of National Defense.
-
Quintiles Names Tom Pike CEO
4/25/2012
Quintiles, the world’s leading global biopharmaceutical services company, today announced the appointment of Tom Pike as chief executive officer.
-
Strength Of Aptalis Pharmaceutical Technologies Patents Confirmed By AMRIX® Verdict
4/25/2012
Aptalis Pharmatech, Inc. (previously known as Eurand, Inc.) and Cephalon, Inc. a wholly-owned subsidiary of Teva Pharmaceuticals Industries Ltd, and Anesta AG prevailed in their appeal to the U.S. Court of Appeals for the Federal Circuit which reversed a lower court’s determination and held that two patents covering the AMRIX® muscle relaxant (Cyclobenzaprine Hydrochloride Extended-Release Capsules) are valid.
-
Cetero Reaches Final Resolution With The Food And Drug Administration
4/24/2012
Leading early-phase Contract Research Organization (CRO) Cetero Research recently announced it has reached a final resolution! with the U.S. Food and Drug Administration (FDA) over studies the company conducted in its Houston bioanalytical laboratory between April 1, 2005 through June 15, 2010.